Cite
HARVARD Citation
Liew, D. et al. (n.d.). THU0616 Elevated thyroid stimulating hormone as a potential biomarker for rheumatic immune-related adverse events following pd-1 inhibitor therapy. Annals of the rheumatic diseases. p. 506. [Online].